In this session, Dr. Ted Liska and Russell Umstead of Moderna Therapeutics will delve into the impacts that Artificial Intelligence (AI), automation, and robotics are having on the biotech industry. They will share their perspectives and experiences on the transformative potential of AI, robotics, and automation in the lab, and their implications for the evolving roles of scientists. Dr. Liska will delve into the integration of AI and Digital Twins in future labs and highlight their importance to strategic preparedness for biotech labs as they navigate and lead in the era of advanced automation. Russell will share his perspective on building automated systems with a holistic data/software-first approach and challenging the speed vs. flexibility automation paradigm.